Navigation Links
MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
Date:10/26/2007

: Due to limited uniformity in RSV testing and local

surveillance reporting, nationwide RSV prevention programs are not

optimal. A nationwide surveillance program was initiated to track and

report RSV activity at the local level in a timely manner. This

abstract includes an interim report of the data collected to date.

-- Regional Respiratory Syncytial Virus Surveillance Data for Georgia and

Implications for Prophylactic Administration of Palivizumab (Poster

#P32) - Mark Eggleston, PharmD, MBA, Saturday, October 27th, 2007 from

12:15 - 1:00 p.m.

BACKGROUND: The Georgia Division of Public Health initiated an RSV

surveillance program in mid-2000 to monitor RSV activity within four

regions of the state. This study aimed to identify the onset, duration,

and peak month of the RSV season in each of the four regions and

evaluate whether national guidelines for RSV prophylaxis with Synagis

are sufficient or whether recommendations should be based on local RSV

virology data.

Additional information about the 2007 AAP National Conference & Exhibition can be found at http://www.aap.org/nce/.

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis, which was a significant product improvement as a monthly intramuscular injection for the prevention of severe RSV, as well as being the first MAb to receive U.S. Food and Drug Administration (FDA) approval for an infectious disease. With the ongoing development of motavizumab, Me
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... near-patient testing, is performed outside a clinical laboratory. ... hence in administrating appropriate treatments and medication. POCT ... and prevalence of lifestyle diseases such as diabetes, ... and user-friendly. POCT devices are standardized to minimize ...
(Date:9/18/2014)... September 18, 2014 Texas Governor ... Sharp, Texas A&M Health Science Center CEO Brett ... of Health and Human Services (HHS), State of ... national pandemic influenza vaccine manufacturing facility in Bryan, ... anchor for the Texas A&M Biocorridor – a ...
(Date:9/18/2014)... Research and Markets has announced ... Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & ... The global companion diagnostics market is expected ... to 2019. Factors such as rising need for personalized ... by the pharmaceutical industry, support from regulatory authorities, and ...
(Date:9/18/2014)... , Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ... previously announced concurrent but separate underwritten offerings of 10,000,000 ... the public of $2.00 per share, for expected gross ... Series A Convertible Preferred Stock at a price to ... proceeds of $20 million. Each share of Series A ...
Breaking Biology Technology:POCT Market in China 2014-2018 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3
... Thought leaders from around the world converge on ... Biomedical, Inc., a,medical technology company that markets the ... a Scientific Advisory Board. The,Board,s purpose is to ... of Provant, new product development, and further,application of ...
... DOYLESTOWN, Pa., May 20 Recognizing National,Hepatitis B Awareness ... Foundation,and the Association of Asian Pacific Community Health Organizations,(AAPCHO) ... the Health Needs of Women and Children," on May ... Honda (CA) and Charles Dent (PA). It,will call urgent ...
... CALGARY, May 20 /PRNewswire-FirstCall/ - Oncolytics Biotech ... that it has been granted,U.S. Patent 7,374,752 ... Disorders." The claims cover pharmaceutical compositions,which comprise ... the Company with additional patent protection for,reovirus ...
Cached Biology Technology:Regenesis Biomedical Appoints Scientific Advisory Board Composed of Life Science and Electronics Experts 2Regenesis Biomedical Appoints Scientific Advisory Board Composed of Life Science and Electronics Experts 3Hepatitis B Foundation and AAPCHO Sponsor Congressional Briefing on 'Zero Tolerance for Hepatitis B' 2Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent 2
(Date:9/18/2014)... of camouflage: you don,t just blend in, the background ... uncommon as you might think. Kathryn Feller, from the ... larval life stages of many marine species are transparent. ... most creatures cannot make transparent. Feller explains that the ... eye unit with an opaque pigment to prevent light ...
(Date:9/17/2014)... the Arts and Humanities has received a $260,000 grant ... project, "The Boundaries of the Human in the Age ... a wide-ranging series of events aimed at exploring two ... artists and researchers who are exploring the boundaries of ... humanism, and the other involves the increasingly influential hypothesis ...
(Date:9/17/2014)... and their environmental impact recently scored a major win. ... on the bags, and Governor Jerry Brown is expected ... not yielding without a fight, according to an article ... newsmagazine of the American Chemical Society. , Alexander Tullo, ... campaign logged its first small victory in 1990 when ...
Breaking Biology News(10 mins):Transparent larvae hide opaque eyes behind reflections 2Mellon Foundation awards grant for major project in the humanities and sciences 2
... (SACRAMENTO, Calif.) A new UC Davis study has found ... those who earn higher wages, adding to growing evidence that ... "Our study clarifies a link that has been assumed but ... study and professor in the UC Davis Center for Healthcare ...
... of a collaborative grant from the Samuel Waxman Cancer ... designed to kill non-Hodgkin lymphoma tumor cells. The breakthrough ... The Foundation-funded investigators include Ari Melnick, M.D., of Weill ... of Maryland and Gilbert Priv, Ph.D., of the University ...
...   , ... PRINCETON, N.J. , May 10 ... R&D services, announced today that it has created a new Discovery & ... immunology services, Biomarker Center of Excellence, and Genomics Laboratory. Leveraging its minority ...
Cached Biology News:UC Davis study links obesity with lowest earnings 2Scientists design new drug type to kill lymphoma cells 2Covance Establishes New Discovery & Translational Services Group 2Covance Establishes New Discovery & Translational Services Group 3
... mm Culture Dishes BD BioCoat Collagen I ... a uniform application of rat tail collagen type ... ,Surface : ECM/attachment factors ,Surface ... : 60 mm x 15 mm ...
The piston kit includes 2 pistons to service one F10 pump of a BioLogic DuoFlow workstation....
BD BioCoat BD MatrigelTM Matrix 100 mm Culture Dishes for hepatocytes, tissue-culture treated polystyrene with a uniform application of MATRIGEL Matrix....
The F40 piston assembly is supplied as two assemblies to service one F40 pump of a BioLogic DuoFlow workstation....
Biology Products: